Allergy and Venous Thromboembolism: A Casual or Causative Association

Abstract

Allergic diseases are very frequent conditions worldwide. The pathogenesis of allergic reactions and venous thromboembolism (VTE) shares several risk factors and predisposing conditions. In particular, the concentration of immunoglobulin E (IgE) is considerably increased in patients with allergic diseases, and this immunoglobulin exert many prothrombotic and antifibrinolytic activities, especially through interaction with mast cells. Therefore, this narrative review is aimed to provide an overview of the current scientific evidence supporting a potential relationship between allergy and the risk of VTE. Although no prospective studies have been published so far, the evidence provided by six large cross-sectional studies and several case reports support the existence of an unquestionable epidemiological association between different allergic diseases (especially atopy, asthma, and celiac disease) and venous thrombosis. Two additional investigations reported that the concentration of IgE might predict the onset of severe complications of pulmonary embolism such as pulmonary infarction and pleural fluid accumulation. Therefore, the existence of a convincing epidemiologic link between allergy and VTE paves the way to future investigations aimed to establish whether the prevention or treatment of allergic diseases might be regarded as an effective measure to lower the risk of VTE.

Keywords

thrombosis - venous thromboembolism - allergy - asthma - atopy

• References

• 1 Pawanker R, Canonica GW, Holgate S, Lockey R. World Allergy Organization. White Book on Allergy 2011–2012. Executive Summary. Milwaukee, WI: World Allergy Organization; 2011
• 2 Raskob GE, Angchaisuksiri P, Blanco AN , et al; ISTH Steering Committee for World Thrombosis Day. Thrombosis: a major contributor to global disease burden. Semin Thromb Hemost 2014; 40 (7) 724-735
• 3 Franchini M, Veneri D, Salvagno GL, Manzato F, Lippi G. Inherited thrombophilia. Crit Rev Clin Lab Sci 2006; 43 (3) 249-290
• 4 Pomero F, Ageno W, Serraino C , et al. The role of inherited thrombophilia in patients with isolated pulmonary embolism: a systematic review and a meta-analysis of the literature. Thromb Res 2014; 134 (1) 84-89
• 5 Heit JA. Epidemiology of venous thromboembolism. Nat Rev Cardiol 2015; 12 (8) 464-474
• 6 Roach RE, Cannegieter SC, Lijfering WM. Differential risks in men and women for first and recurrent venous thrombosis: the role of genes and environment. J Thromb Haemost 2014; 12 (10) 1593-1600
• 7 Kreidy R. Influence of acquired and genetic risk factors on the prevention, management, and treatment of thromboembolic disease. Int J Vasc Med 2014; 2014: 859726
• 8 Virchow R. Phlogose und Thrombose im Gefäßsystem; Gesammelte Abhandlungen zur Wissenschaftlichen Medizin. Frankfurt: Staatsdruckerei; 1856
• 9 Koutroumpakis EI, Tsiolakidou G, Koutroubakis IE. Risk of venous thromboembolism in patients with inflammatory bowel disease. Semin Thromb Hemost 2013; 39 (5) 461-468
• 10 Yusuf HR, Hooper WC, Grosse SD, Parker CS, Boulet SL, Ortel TL. Risk of venous thromboembolism occurrence among adults with selected autoimmune diseases: a study among a U.S. cohort of commercial insurance enrollees. Thromb Res 2015; 135 (1) 50-57
• 11 Kim V, Goel N, Gangar J , et al; and the COPD Gene Investigators. Risk factors for venous thromboembolism in chronic obstructive pulmonary disease. Chronic Obstr Pulm Dis (Miami) 2014; 1 (2) 239-249
• 12 Farmer RD, Lawrenson RA, Todd JC, Williams TJ, MacRae K. Oral contraceptives and venous thromboembolic disease. Analyses of the UK General Practice Research Database and the UK Mediplus database. Hum Reprod Update 1999; 5 (6) 688-706
• 13 Huerta C, Johansson S, Wallander MA, García Rodríguez LA. Risk factors and short-term mortality of venous thromboembolism diagnosed in the primary care setting in the United Kingdom. Arch Intern Med 2007; 167 (9) 935-943
• 14 Undas A, Cieśla-Dul M, Drążkiewicz T, Potaczek DP, Sadowski J. Association between atopic diseases and venous thromboembolism: a case-control study in patients aged 45 years or less. J Thromb Haemost 2011; 9 (4) 870-873
• 15 Cazzola M, Calzetta L, Bettoncelli G, Novelli L, Cricelli C, Rogliani P. Asthma and comorbid medical illness. Eur Respir J 2011; 38 (1) 42-49
• 16 Majoor CJ, Kamphuisen PW, Zwinderman AH , et al. Risk of deep vein thrombosis and pulmonary embolism in asthma. Eur Respir J 2013; 42 (3) 655-661
• 17 Chung WS, Lin CL, Ho FM , et al. Asthma increases pulmonary thromboembolism risk: a nationwide population cohort study. Eur Respir J 2014; 43 (3) 801-807
• 18 Doru FA, Erkan L, Findik S, Uzun O, Atici A. Correlation of serum IgE levels with severity of acute pulmonary thromboembolism [in Turkish]. Tuberk Toraks 2004; 52 (1) 24-30
• 19 Takekawa H, Miyamoto K, Yamaguchi E, Munakata M, Kawakami Y. Acute rise in serum immunoglobulin E concentration in pulmonary thromboembolism. Chest 1993; 104 (1) 61-64
• 20 Gabrielli M, Santoliquido A, Gasbarrini G, Pola P, Gasbarrini A. Latent coeliac disease, hyperhomocysteinemia and pulmonary thromboembolism: a close link?. Thromb Haemost 2003; 89 (1) 203-204
• 21 Beyan E, Pamukcuoglu M, Beyan C. Deep vein thrombosis associated with celiac disease. Bratisl Lek Listy (Tlacene Vyd) 2009; 110 (4) 263-264
• 22 Liu H, Al-Quran SZ, Lottenberg R. Thrombotic storm in Kimura disease. J Thromb Thrombolysis 2010; 29 (3) 354-357
• 23 Baryshnikov EN, Krums LM, Vorob'eva NN, Parfenov AI. [Lower extremity deep vein thrombosis associated with gluten-sensitivity celiac disease]. Ter Arkh 2010; 82 (2) 52-54
• 24 Jones PD, Moll S, Dellon ES. Pulmonary embolism in a patient with eosinophilic esophagitis: causal or coincidental?. Case Rep Gastroenterol 2013; 7 (1) 82-88
• 25 Okur A, İntepe YS, Serin HI, Yıldırım U, Mavili E. Recurrent pulmonary embolism in an asthmatic patient who had interrupted inferior vena cava with azygous continuation. Turk Kardiyol Dern Ars 2014; 42 (3) 277-280
• 26 Lippi G, Franchini M, Targher G. Arterial thrombus formation in cardiovascular disease. Nat Rev Cardiol 2011; 8 (9) 502-512
• 27 Lippi G, Franchini M, Favaloro EJ. Unsuspected triggers of venous thromboembolism—trivial or not so trivial?. Semin Thromb Hemost 2009; 35 (7) 597-604
• 28 Lippi G, Franchini M, Favaloro EJ. Holiday thrombosis. Semin Thromb Hemost 2011; 37 (8) 869-874
• 29 Windebank WJ, Boyd G, Moran F. Pulmonary thromboembolism presenting as asthma. BMJ 1973; 1 (5845) 90-94
• 30 Joos GF, Brusselle GG, Van Hoecke H, Van Cauwenberge P, Bousquet J, Pauwels RA. Positioning of glucocorticosteroids in asthma and allergic rhinitis guidelines (versus other therapies). Immunol Allergy Clin North Am 2005; 25 (3) 597-612 , vii–viii
• 31 Johannesdottir SA, Horváth-Puhó E, Dekkers OM , et al. Use of glucocorticoids and risk of venous thromboembolism: a nationwide population-based case-control study. JAMA Intern Med 2013; 173 (9) 743-752
• 32 Higgins PD, Skup M, Mulani PM, Lin J, Chao J. Increased risk of venous thromboembolic events with corticosteroid vs biologic therapy for inflammatory bowel disease. Clin Gastroenterol Hepatol 2015; 13 (2) 316-321
• 33 van Zaane B, Stuijver DJ, Squizzato A, Gerdes VE. Arterial and venous thrombosis in endocrine diseases. Semin Thromb Hemost 2013; 39 (5) 489-495
• 34 Lippi G, Cervellin G, Sanchis-Gomar F. Immunoglobulin E (IgE) and ischemic heart disease. Which came first, the chicken or the egg?. Ann Med 2014; 46 (7) 456-463
• 35 Potaczek DP. Links between allergy and cardiovascular or hemostatic system. Int J Cardiol 2014; 170 (3) 278-285
• 36 Lenting PJ, Denis CV, Wohner N. Von Willebrand factor and thrombosis: risk factor, actor and pharmacological target. Curr Vasc Pharmacol 2013; 11 (4) 448-456
• 37 Jenkins PV, Rawley O, Smith OP, O'Donnell JS. Elevated factor VIII levels and risk of venous thrombosis. Br J Haematol 2012; 157 (6) 653-663
• 38 Buyukyilmaz G, Soyer OU, Buyuktiryaki B, Alioglu B, Dallar Y. Platelet aggregation, secretion, and coagulation changes in children with asthma. Blood Coagul Fibrinolysis 2014; 25 (7) 738-744
• 39 Lippi G, Maffulli N. Biological influence of physical exercise on hemostasis. Semin Thromb Hemost 2009; 35 (3) 269-276